NASDAQ · Analyst Forecast

OKYO Pharma Limited (OKYO) Stock Forecast & Price Target

$1.11 NASDAQ: OKYO Market Cap $57.99M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering OKYO Pharma Limited (OKYO), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For OKYO Pharma Limited, the average estimate for 2031 earnings per share is 0.20; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$1.11
Consensus targetThe average of the price targets analysts have published.$5.00
Median targetThe middle target, less affected by a single outlier.$5.00
Highest targetThe most optimistic published target.$5.00
Lowest targetThe most pessimistic published target.$5.00
Difference from priceHow far the consensus target sits from today’s price.+350.5%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (reporting currency)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
20260001
20270001
202811.00M11.00M11.00M1
202932.20M32.20M32.20M1
203055.20M55.20M55.20M1
203190.80M90.80M90.80M1

Earnings per share forecast

YearLowAverageHighAnalysts
2026−0.10−0.10−0.101
2027−0.14−0.14−0.141
2028−0.41−0.41−0.411
2029−0.59−0.59−0.591
2030−0.29−0.29−0.291
20310.200.200.201

OKYO Pharma Limited (OKYO) forecast — frequently asked questions

What is the analyst price target for OKYO Pharma Limited?

Analysts covering OKYO Pharma Limited (OKYO) have a consensus price target of $5.00, 350.5% above the current price of $1.11. Published targets range from $5.00 to $5.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for OKYO Pharma Limited's earnings?

The average analyst estimate for OKYO Pharma Limited (OKYO) earnings per share in 2031 is 0.20, with individual estimates between 0.20 and 0.20.

How much revenue is OKYO Pharma Limited expected to make?

Analysts forecast OKYO Pharma Limited (OKYO) revenue of 90.80M in 2031, based on 1 published estimates.

How many analysts cover OKYO?

1 analyst contribute estimates for OKYO Pharma Limited (OKYO). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.